Goldman Sachs’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
|
|||||
|
2025
Q1 | $996K | Buy |
|
|||||
|
2024
Q4 | $2.07M | Buy |
|
|||||
|
2024
Q3 | $2.88M | Sell |
|
|||||
|
2024
Q2 | $3.41M | Sell |
|
|||||
|
2024
Q1 | $10.5M | Buy |
|
|||||
|
2023
Q4 | $641K | Sell |
|
|||||
|
2023
Q3 | $407K | Sell |
|
|||||
|
2023
Q2 | $634K | Sell |
|
|||||
|
2023
Q1 | $1.09M | Buy |
|
|||||
|
2022
Q4 | $1.68M | Sell |
|
|||||
|
2022
Q3 | $3.69M | Buy |
|
|||||
|
2022
Q2 | $993K | Buy |
|
|||||
|
2022
Q1 | $2.91M | Sell |
|
|||||
|
2021
Q4 | $7.24M | Sell |
|
|||||
|
2021
Q3 | $11.8M | Buy |
|
|||||
|
2021
Q2 | $8.74M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $418K | Buy |
|